<SEC-DOCUMENT>0001656472-25-000047.txt : 20250319
<SEC-HEADER>0001656472-25-000047.hdr.sgml : 20250319
<ACCEPTANCE-DATETIME>20250319073608
ACCESSION NUMBER:		0001656472-25-000047
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250319
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250319
DATE AS OF CHANGE:		20250319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cronos Group Inc.
		CENTRAL INDEX KEY:			0001656472
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38403
		FILM NUMBER:		25750871

	BUSINESS ADDRESS:	
		STREET 1:		4491 CONCESSION RD 12
		CITY:			STAYNER
		STATE:			A6
		ZIP:			L0M 1S0
		BUSINESS PHONE:		(416) 504-0004

	MAIL ADDRESS:	
		STREET 1:		6D - 7398 YONGE ST
		STREET 2:		PMB 732
		CITY:			THORNHILL
		STATE:			A6
		ZIP:			L4J 8J2

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PharmaCan Capital Corp.
		DATE OF NAME CHANGE:	20151021
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cron-20250319.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:478b2790-72bd-426c-9418-d37cb427892c,g:2f398438-9d39-48cc-adba-90bc3125063a,d:f56f6ba78b4f431aaa3529025509a1b7-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cron-20250319</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-16">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-17">0001656472</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cron-20250319.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-08</xbrli:startDate><xbrli:endDate>2024-08-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if56f6ba78b4f431aaa3529025509a1b7_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:10.15pt;padding-left:4.35pt;padding-right:4.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:0.3pt;padding-left:4.35pt;padding-right:4.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:1.45pt;padding-left:4.35pt;padding-right:4.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:1.45pt;padding-left:4.35pt;padding-right:4.35pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-top:1.45pt;text-align:center"><span><br/></span></div><div style="padding-left:4.37pt;padding-right:4.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="padding-left:4.37pt;padding-right:4.37pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="padding-left:4.37pt;padding-right:4.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="padding-left:4.35pt;padding-right:4.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:123%">Pursuant to Section 13 or 15(d)</span></div><div style="padding-left:4.35pt;padding-right:4.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">of the Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div style="padding-left:4.37pt;padding-right:4.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">March 19, 2025</ix:nonNumeric></span></div><div style="padding-left:4.37pt;padding-right:4.37pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="padding-left:4.37pt;padding-right:4.37pt;text-align:center"><span><br/></span></div><div style="padding-left:4.35pt;padding-right:4.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">CRONOS GROUP INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"/><td style="width:30.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.45pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">British Columbia, Canada</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.45pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">001-38403</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.45pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Commission</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.910%"><tr><td style="width:1.0%"/><td style="width:37.125%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.249%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-4">4491 Concession Rd 12</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stayner, Ontario</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-5">L0M 1S0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:0.45pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-6">416</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-7">504-0004</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:0.45pt;padding-left:4.37pt;padding-right:4.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">N/A</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-8">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-10">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-11">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-12">Common Shares, no par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-13">CRON</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-14">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:5pt"><span><br/></span></div><div style="padding-left:5pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:127%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></div><div style="text-align:right"><span><br/></span></div><div style="padding-left:4.5pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:121%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#9744;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if56f6ba78b4f431aaa3529025509a1b7_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02.&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of March 19, 2025 (the &#8220;Effective Date&#8221;), Cronos Group Inc. (the &#8220;Company&#8221;) has appointed Anna Shlimak, the Company&#8217;s Chief Strategy Officer, as the Company&#8217;s Chief Financial Officer. As of the Effective Date, James Holm will no longer serve as the Company&#8217;s Chief Financial Officer. Mr. Holm will continue to be employed by the Company and Cronos USA Client Services LLC (&#8220;Cronos USA&#8221;) through April 18, 2025 (the &#8220;Separation Date&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Shlimak, age 39, joined the Company in May 2018 as Head of Investor Relations &amp; Communications and was responsible for developing relationships with investors and sell side analysts, as well as creating investor communication and reporting. In February 2020, Ms. Shlimak became the Company&#8217;s Senior Vice President, Corporate Affairs.   From July 2020 to August 2024, Ms. Shlimak served as the Company&#8217;s Senior Vice President, Head of Strategy &amp; Corporate Affairs, where she was responsible for managing and directing the organization&#8217;s internal and external communications, government affairs, investor relations and corporate strategy, before becoming the Company&#8217;s Chief Strategy Officer in September 2024.  Prior to joining the Company, Ms. Shlimak was the Head of Investor Relations at Quest Partners LLC, a research driven alternative investment firm.  Ms. Shlimak was responsible for business development, investor reporting, marketing and communication initiatives for the fund. Previously, Ms. Shlimak held a range of diverse roles at the New York Stock Exchange in both the New York and London offices.  She received a Master of Business Administration from Columbia Business School and holds a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Shlimak Employment Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Ms. Shlimak&#8217;s appointment, on March 19, 2025 Cronos USA, the Company and Ms. Shlimak entered into an amended and restated executive employment agreement (the &#8220;Shlimak Employment Agreement&#8221;) setting forth the terms and conditions of Ms. Shlimak&#8217;s employment.  Pursuant to the Shlimak Employment Agreement, Ms. Shlimak will receive an annual base salary of $372,000 and will be eligible for an annual target bonus opportunity of 115% of annual base salary.  Starting in the 2026 fiscal year, Ms. Shlimak will be eligible to receive annual grants of equity-based awards with an initial long-term target incentive opportunity of 115% of annual base salary.  Additionally, Ms. Shlimak will receive a one-time equity award in the form of restricted stock units with a grant date fair value of $157,800.  Ms. Shlimak will also be eligible to participate in employee benefit programs of Cronos USA on the same terms as other similarly situated employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event Ms. Shlimak&#8217;s employment is terminated by Cronos USA without Just Cause or she resigns for Good Reason (each, as defined in the Shlimak Employment Agreement), she would be entitled to a severance payment in the amount of her annual base salary, employee benefit continuation for up to one year following termination, and a pro-rated annual bonus for the year of termination, subject to Ms. Shlimak entering into a release of claims in favor of the Company and its affiliates and related entities.  Upon termination of her employment for any reason, Ms. Shlimak will be subject to: (i) ongoing confidentiality and mutual non-disparagement provisions; (ii) non-competition and customer non-solicitation covenants for the one-year period following termination; and (iii) an employee non-solicitation covenant for the two-year period following termination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Holm Separation Agreement </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Mr. Holm&#8217;s separation, on March 19, 2025 Cronos USA, the Company and Mr. Holm entered into a separation agreement (the &#8220;Holm Separation Agreement&#8221;).  Following the Separation Date, subject to Mr. Holm entering into a release of claims in favor of the Company and its affiliates and Mr. Holm&#8217;s compliance with the terms of the Holm Separation Agreement and his post-employment obligations, Mr. Holm will receive (1) cash severance in an aggregate amount equal to $385,000, which represents one year of Mr. Holm&#8217;s base salary, payable within 30 days after the Separation Date, and (2) $20,260, which is equal to one year of Cronos USA&#8217;s portion of Mr. Holm&#8217;s benefits premiums, to cover some of the costs of continuing Mr. Holm&#8217;s group insured benefits following the Separation Date.  Mr. Holm will be eligible to receive a prorated annual cash bonus award in respect </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the 2025 fiscal year of $104,046.25.  In addition, as of the Separation Date, the Company will accelerate the vesting of the unvested portion of Mr. Holm&#8217;s stock option award granted in November 2022, which will be exercisable in accordance with the terms of the applicable award agreement until October 18, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Holm will remain subject to an ongoing non-disparagement provision, ongoing confidentiality and intellectual property provisions, and the non-competition and non-solicitation requirements contained in his employment agreement, dated November 14, 2022 (the &#8220;Holm Employment Agreement&#8221;), by and among Cronos USA, the Company and Mr. Holm.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing descriptions of the Shlimak Employment Agreement, Holm Separation Agreement and Holm Employment Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of: (i) the Shlimak Employment Agreement and Holm Separation Agreement, which are attached hereto as Exhibits 10.1 and 10.2, respectively, and incorporated herein by reference; and (ii) the Holm Employment Agreement, which is attached as Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on November 14, 2022.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:3.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"/><td style="width:12.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:82.561%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit101-shlimakexecutiv.htm">Amended and Restated Executive Employment Agreement, dated March 19, 2025, by and among Cronos USA, the Company and Anna Shlimak.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit102-holmseparationa.htm">Separation Agreement, dated March 19, 2025, by and among Cronos USA, the Company and James Holm.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File &#8211; The cover page from Cronos Group Inc.&#8217;s Current Report on Form 8-K filed on March 19, 2025 is formatted in Inline XBRL.</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8.35pt;padding-left:4.35pt;padding-right:4.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:0.45pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:0.45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.254%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CRONOS GROUP INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: March 19, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael Gorenstein</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name: Michael Gorenstein</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title: President and Chief Executive Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-shlimakexecutiv.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i4c834372a72c488fbc010f95ac38bc15_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBIT 10.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDED AND RESTATED<br>EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BETWEEN&#58;</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS USA CLIENT SERVICES LLC</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and -</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ANNA SHLIMAK</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) </font></div><div><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- and -&#160;&#160;&#160;&#160;</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">solely for the purposes specified herein,</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS GROUP INC.</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)<br></font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Company is a wholly owned subsidiary of Cronos Group&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Executive is currently employed by the Company pursuant to an employment agreement executed by the Executive on February 20, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Original Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and amended pursuant to written amendments effective February 17, 2022, February 21, 2023 and August 23, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Amending Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in the position of Chief Strategy Officer&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Company wishes to promote the Executive to the position of Chief Financial Officer of Cronos Group&#59;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Executive will continue to have extensive access to the customers, vendors, suppliers, distribution processes and other unique and valuable confidential information and trade secrets of the Company, Cronos Group and their respective affiliates (excluding Altria Group, Inc. and its subsidiaries) and related entities (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Company and the Executive desire to amend and restate the Original Agreement, including the Amending Agreements, in its entirety by this Agreement effective as of the Effective Date&#59; </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AND WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Executive acknowledges that this Agreement, including the proprietary rights, confidentiality, non-solicitation and non-competition provisions that form part of this Agreement are essential to protect the legitimate business interests of the Group&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;NOW THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in consideration of the foregoing, the mutual covenants and agreements contained in this Agreement, and other good and valuable consideration, including the increased base salary set out at Section 5.1, target bonus opportunity set out at Section 5.2, and target incentive opportunity set out at Section 5.4, the receipt and sufficiency of which are hereby acknowledged, the Company and the Executive, and solely for the purposes specified herein, Cronos Group (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), agree as follows&#58;<br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Position</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The Executive will be employed by the Company in the position of Chief Financial Officer of Cronos Group effective as of March 19, 2025 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Location</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The Executive shall be based primarily from the Executive&#8217;s home office. During the term of the Executive&#8217;s employment with the Company, the Executive&#8217;s principal place of residence shall remain in the United States. The Executive shall be available for business travel as reasonably required to perform the Executive&#8217;s duties hereunder.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Work Authorizations</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">It is a condition of this Agreement and the Executive&#8217;s employment that the Executive shall be able to work lawfully in the United States. However, it is understood and agreed that the Executive&#8217;s position may require that the Executive work abroad, as needed by the Group. The Executive&#8217;s employment with the Company is therefore also conditional upon the securing of all necessary visas, work permits and other authorizations that may be required to enter or work in any of the countries in which the Executive may be assigned to work or visit during the term of employment. The Company shall provide reasonable assistance in respect of immigration matters. Despite such assistance, the Company cannot guarantee when or whether the Executive&#8217;s application for a work permit, visa, permanent residence status or other immigration status or documents will be approved. At any time, should necessary authorizations that permit the Executive to legally work in the United States or in any other jurisdiction in which the Executive will be required to work or visit not be obtained or expire without the possibility of renewal, the Executive&#8217;s employment shall come to an end and shall be treated by the Company as a termination without Just Cause (as defined below)&#59; provided, that if such authorization expires without the possibility of renewal due to any action or inaction by the Executive, the Executive&#8217;s employment shall come to an end and shall be treated by the Company as a termination with Just Cause.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Employment Duties</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The Executive shall perform such duties and exercise such powers as are normally associated with or incidental and ancillary to the Executive&#8217;s position and as may be assigned to the Executive from time to time. In fulfilling the Executive&#8217;s duties to the Company, the Executive shall be instructed by and shall regularly report to the Chief Executive Officer of Cronos Group (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) or the Chair of the Audit Committee of the board of directors of Cronos Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Executive&#8217;s duties, hours of work, location of employment and reporting relationships may be adjusted from time to time by the Company to meet changing business  and operational needs. Without limiting the foregoing, the Executive shall&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">devote the Executive&#8217;s full working time and attention during normal business hours and such other times as may be reasonably required to the business and affairs of the Group and shall not, without the prior written consent of the CEO, undertake any other business (including any position on a board of any for profit, public benefit, nonprofit or other entity) or occupation or public office&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">perform those duties that may be reasonably assigned to the Executive diligently, honestly, and faithfully to the best of the Executive&#8217;s ability and in the best interest of the Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">abide by all Cronos Group policies, as instituted and amended from time to time, including the Cronos Group - Employee Handbook (United States)&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">use best efforts to promote the interests and goodwill of the Group and not knowingly do, or permit to be done, anything that may be prejudicial to the Group&#8217;s interests, it being understood and agreed that the Executive is a fiduciary of Cronos Group and owes fiduciary obligations to Cronos Group that are not extinguished or limited by this Agreement&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">identify and immediately report to the CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any gross misrepresentations or violations of any Cronos Group policy, including the Cronos Group &#8211; Employee Handbook (United States) or applicable law or stock exchange rule by Cronos Group or its management. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Compensation and Benefits</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company shall pay the Executive an annual base salary of US$372,000, less applicable deductions and withholdings (as in effect from time to time, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Base Salary shall be paid by direct deposit on a bi-weekly basis, in accordance with the Company&#8217;s payroll practices (as may be amended from time to time by the Company in its sole discretion). Any changes to Base Salary shall be at the sole discretion of the Company.  The Base Salary shall be subject to increases, but not decreases.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Annual Performance Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive shall be eligible to participate in the Group&#8217;s annual cash bonus plan as may be in effect from time to time, and to receive an annual bonus, subject to the terms and conditions of that plan as determined by Cronos Group at its sole discretion. The Executive&#8217;s annual target bonus opportunity shall increase to 115% of Base Salary, provided that the actual bonus amount, if any, shall be determined pursuant to the terms of the applicable Group annual bonus plan. The Company reserves the right to amend or terminate any annual bonus plan established or adopted at any time, without notice or further obligation. Subject to Section 6.3, the Executive must be actively employed by the Company on the applicable payment date to be eligible for any annual bonus, unless provided otherwise pursuant to the applicable annual cash bonus plan. For certainty, if the Executive&#8217;s employment is terminated by the Company with or without Just Cause, or the Executive resigns or otherwise terminates employment for any reason, the Executive shall cease to be &#8220;actively employed&#8221; on the last day of employment as specified in the Company&#8217;s or the Executive&#8217;s written notice of termination, as applicable, shall not be considered &#8220;actively employed&#8221; during any period of notice, pay in lieu of notice, severance payment or similar amount, and shall not be entitled to an annual bonus (or any part thereof) or damages in lieu of the Executive&#8217;s eligibility for a bonus, unless provided otherwise pursuant to Section 6.3 or the applicable annual cash bonus plan. There shall be no guarantee of a bonus in any given year. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Long-Term Incentive Opportunity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Starting in the Group&#8217;s 2026 fiscal year, the Executive shall be eligible to receive annual grants of equity-based awards over shares of Cronos Group with an initial target incentive opportunity of 115% of Base Salary (based on the grant date fair value of such awards), provided that the actual amount, if any, of the grants shall be determined by the Board or the Compensation Committee of the Board, as applicable, at its sole discretion. Any equity-based grants shall be governed by the terms and conditions of the equity award plan or any other applicable plan of Cronos Group and the applicable award agreement, except as expressly set forth herein. Such plan or plans may be amended from time to time at Cronos Group&#8217;s sole discretion. In the event of the cessation of the Executive&#8217;s employment for any reason, the Executive&#8217;s entitlements in respect of any equity-based awards shall be governed by the terms and conditions of the applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">equity award plan, any other applicable plan and the applicable award agreement, except as expressly set forth herein. The Executive shall not be eligible for any further grants of equity-based awards following the effective date of termination or damages in lieu thereof, regardless of any applicable notice period, pay in lieu of notice, severance payment or similar amount. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">In addition, subject to the approval of the Board, the Executive shall receive, as soon as reasonably practicable following the Effective Date, a one-time award of restricted share units with a grant date fair value of US$157,800, based on the grant date fair value of such award (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">One-Time Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The One-Time Award shall be subject to the terms and conditions set forth in Cronos Group&#8217;s 2020 Omnibus Equity Incentive Plan and the applicable award agreement, with vesting terms substantially similar to those applicable to annual grants of equity-based awards for 2025 to similarly situated executives. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Group Insured Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive shall be eligible to participate in the benefits programs of the Company or Cronos Group, as applicable, for health and dental, life insurance, disability and other benefits as may be available to employees of the Company from time to time, subject to the terms and conditions of the applicable plan document. The Company or the Group, as applicable, reserves the right to alter, amend or discontinue all benefits, coverages, plans and programs referred to in this Section 5.4, without advance notice or other obligation. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Vacation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive shall be eligible to participate in the Company&#8217;s flexible, self-managed vacation program, in accordance with the Company&#8217;s vacation policy, as amended from time to time. Under this program, there is no cap on the actual amount of vacation that may be taken in a given year&#59; however, employees must exercise good judgment and anticipate important business activities, deliverables and deadlines when scheduling vacation. The Executive shall take vacation time at such times as are approved in advance by the Company in accordance with the policies of the Company. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Business Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive shall be reimbursed for all reasonable travel and other out-of-pocket expenses properly incurred by the Executive from time to time in connection with performance of the Executive&#8217;s duties and submitted for reimbursement in accordance with the following sentence of this Section&#160;5.7. The Executive shall furnish to the Company all invoices or statements in respect of expenses for which the Executive seeks reimbursement in accordance with the Company&#8217;s policies or procedures for expense reimbursement, as may be amended from time to time. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Clawback Policy&#59; Share Ownership Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Executive agrees and acknowledges that any annual, long-term or other cash, equity or equity-based incentive or bonus compensation paid, provided or awarded to the Executive, including, notwithstanding anything to the contrary in such policy, the stock options and restricted share units awarded in connection with the One-Time Awards, is subject to the terms and conditions of any clawback or recapture policy that Cronos Group may adopt from time to time, and may be subject to the requirement that such compensation be repaid to the Company after it has been distributed to the Executive. The Executive agrees and acknowledges that the Executive shall be subject to Cronos Group&#8217;s share ownership guidelines for the Executive&#8217;s position, as the same may be in effect or amended from time to time. As of the Effective Date, such guidelines require the Executive to achieve, within five years of the date such guidelines became effective and thereafter during the term of the Executive&#8217;s employment with the Company, a level of ownership equal to two times Base Salary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Termination of Employment</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Termination by the Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Executive may terminate the Executive&#8217;s employment with the Company at any time by providing the Company with at least three months of notice in writing. If, upon receipt of the Executive&#8217;s resignation (or any later date during such notice period), the Company terminates the Executive&#8217;s employment before the date the resignation was to be effective, the Company shall, in full satisfaction of its obligations to the Executive&#58; (a) pay </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Executive&#8217;s Base Salary and vacation pay accrued until the date the resignation was to be effective up to a maximum of three months&#59; and (b) reimburse the outstanding expenses properly incurred by the Executive until the date the Executive&#8217;s employment ceases and submitted for reimbursement pursuant to Section 5.7. In such circumstances the Executive shall be ineligible for any pro-rated bonus for the year of termination, and any entitlements in respect of any equity-based awards shall be governed by the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Termination by the Company for Just Cause or on Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may terminate the Executive&#8217;s employment at any time for Just Cause without prior notice or in the event of the Executive&#8217;s death or Disability (as defined below). On the termination of the Executive&#8217;s employment for Just Cause or on the Executive&#8217;s death or Disability, this Agreement and the Executive&#8217;s employment shall terminate and the Company shall, in full satisfaction of its obligations to the Executive&#58; (a) pay the Executive&#8217;s Base Salary and vacation pay accrued until the date the Executive&#8217;s employment ceases&#59; and (b) reimburse the outstanding expenses properly incurred by the Executive until the date the Executive&#8217;s employment ceases and submitted for reimbursement pursuant to Section 5.7. In such circumstances the Executive shall be ineligible for any pro-rated bonus for the year of termination, and any entitlements in respect of equity-based awards shall be governed by the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement. For the purposes of this Agreement, (A) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Just Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58; (i) any act or omission constituting &#8220;just cause&#8221; for dismissal without notice under applicable law&#59; (ii) the Executive&#8217;s repeated failure or refusal to perform the Executive&#8217;s principal duties and responsibilities after notice from the CEO or other officer of the Company&#59; (iii) misappropriation of the funds or property of the Company&#59; (iv) use of alcohol or drugs in violation of the Company&#8217;s policies or in a manner that interferes with the Executive&#8217;s obligations under this Agreement&#59; (v) the indictment, arrest or conviction in a court of law for, or the entering of a plea of guilty or nolo contendere to, a summary or indictable offence or any crime involving moral turpitude, fraud, dishonesty or theft (subject to the Company&#8217;s obligations under applicable law)&#59; (vi) engaging in any act which is a violation of any law, regulation or Cronos Group policy, that, if violated, injures or could reasonably be expected to injure the reputation, business or business relationships of the Group&#59; (vii) engaging in any act which is a violation of any Cronos Group policy with respect to sexual harassment, discrimination or similar or related policies&#59; or (viii) any act which injures or could reasonably be expected to injure the reputation, business or business relationships of the Group, and (B) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a physical or mental incapacity of the Executive that has prevented the Executive from performing the duties customarily assigned to the Executive for 180 calendar days, whether or not consecutive, out of any twelve consecutive months and that in the opinion of the Company, acting on the basis of advice from a duly qualified medical practitioner, is likely to continue to a similar degree.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Termination by the Company without Just Cause or Resignation for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may terminate the Executive&#8217;s employment at any time without Just Cause, on providing thirty days&#8217; written notice to the Executive. The Executive may resign from the Executive&#8217;s employment for Good Reason (as defined below) on providing thirty days&#8217; written notice to the Company. If (a) the Company terminates the Executive&#8217;s employment without Just Cause, or (b) the Executive resigns from the Executive&#8217;s employment for Good Reason, and in each case, if the Executive signs, delivers to the Company, and does not revoke a release in favor of the Group to the Company in the form attached as&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;to this Agreement, the Company, shall, in full satisfaction of its obligations to the Executive&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">pay the Executive&#8217;s Base Salary and accrued but unpaid vacation pay in accordance with applicable legislation&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">reimburse the Executive&#8217;s expenses properly incurred until the date the Executive&#8217;s employment ceases and properly submitted in accordance with the Company&#8217;s policies&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">provide the Executive with a payment equal to the annual Base Salary, payable within sixty days following the Executive&#8217;s date of termination&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">continue the Executive&#8217;s group insured benefits at active employee rates under the Consolidated Omnibus Reconciliation Act of 1985, as amended, for one year following the Executive&#8217;s date of termination, or until the date on which the Executive obtains alternate benefit coverage, whichever occurs first, subject to the terms and conditions of the benefit plans, as amended from time to time. If the Company is unable for any reason to continue its contributions to the benefit plans as set out in this Agreement, it shall pay the Executive an amount equal to the Company&#8217;s required contributions to such benefit plans on behalf of the Executive for such period. The Executive agrees that the Executive is required to notify the Company when the Executive obtains alternate life, medical and dental benefit coverage&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">subject to the terms and conditions of the Group&#8217;s annual cash bonus plan in effect at such time, provide the Executive with an annual performance bonus in respect of the fiscal year in which the Executive&#8217;s employment terminates. The annual bonus, if any, shall be (i) prorated based on the number of complete months of such fiscal year during which the Executive was actively employed up to the date of the Executive&#8217;s termination of employment, and (ii) payable as a lump sum when annual bonuses in respect of the fiscal year are paid to other senior executives of the Company. Any assessment of the Company&#8217;s and the Executive&#8217;s year-to-date performances for purposes of determining the amount of the annual cash bonus, if any, shall be at the Company&#8217;s sole discretion. For the avoidance of doubt and notwithstanding anything to the contrary in the foregoing, if the Executive&#8217;s employment terminates after the end of a fiscal year, but before the payment of any annual performance bonus in respect of such year, the Executive shall only be eligible for a performance bonus in respect of such completed fiscal year, and shall not be eligible for a prorated bonus in respect of any subsequent fiscal year(s)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">determine the Executive&#8217;s entitlements in respect of equity-based awards in accordance with the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement. </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Executive does not sign and deliver to the Company the release in favor of the Group described above, or if the Executive revokes the foregoing release, the Company shall only provide the Executive with such compensation (including any Base Salary and accrued but unpaid vacation pay, termination pay, severance pay and expense reimbursements submitted in accordance with Section 5.7) and benefits that are expressly required pursuant to applicable law, if any.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events without the Executive&#8217;s consent, except in each case for any action not taken in bad faith and which is remedied by the Company within thirty days after a written notice thereof by the Executive (provided that such written notice must be received by the Company within sixty days of the Executive becoming aware of such condition)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the assignment to the Executive of duties materially different than the duties assigned to the Executive hereunder&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">a material diminution in the Executive&#8217;s title, status, seniority, responsibilities or authority or a requirement to report to any person other than the Company&#8217;s CEO or the Chair of the Audit Committee of the Board&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">the Company requiring relocation of the Executive&#8217;s principal place of employment&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">a material reduction in the Executive&#8217;s Base Salary, target bonus opportunity or target long-term incentive opportunity&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">a material breach by the Company of the terms of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Resignation on Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive agrees that upon any termination of employment with the Company for any reason the Executive shall immediately tender resignation from any position the Executive may hold as an officer or director of the Company and take all steps necessary to remove the Executive from any and all designated positions (a) under any applicable laws, including the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Cannabis Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (Canada) and the regulations thereunder, as the same may be amended from time to time, (b) with any subsidiary or affiliate of Cronos Group or (c) held by the Executive as a result of any Group member&#8217;s contractual rights. If the Executive fails to comply with this obligation within three days of the Executive&#8217;s termination or resignation, the Executive hereby irrevocably authorizes Cronos Group to appoint a person in the Executive's name and on the Executive's behalf to sign or execute any documents and&#47;or do all things necessary or requisite to give effect to such resignation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Executive understands and agrees that the entitlements under this Article 6 are provided in full satisfaction of the Executive&#8217;s entitlements to notice of termination, pay in lieu of notice, and severance pay, if any, under this Agreement, any employee benefit plan sponsored or maintained by the Group, applicable law (including the common law) or otherwise.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Restrictive Covenants</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">during the term of the Executive&#8217;s employment, the Executive may be given access to or may become acquainted with confidential and proprietary information of the Group and third parties to which the Group may have any obligations of non-disclosure or confidentiality, including&#58; trade secrets&#59; know-how&#59; Intellectual Property (as defined below)&#59; Executive-Developed IP (as defined below), Development Records (as defined below), existing and contemplated work product resulting from or related to projects performed or to be performed by or for the Group&#59; programs and program modules&#59; processes&#59; algorithms&#59; design concepts&#59; system designs&#59; production data&#59; test data&#59; research and development information&#59; information regarding the acquisition, protection, enforcement and licensing of proprietary rights&#59; technology&#59; joint ventures&#59; business, accounting, engineering and financial information and data&#59; marketing and development plans and methods of obtaining business&#59; forecasts&#59; future plans and strategies of the Group&#59; pricing, cost, billing and fee arrangements and policies&#59; quoting procedures&#59; special methods and processes&#59; lists and&#47;or identities of customers, suppliers, vendors and contractors&#59; the type, quantity and specifications of products and services purchased, leased, licensed or received by the Group and&#47;or any of its customers, suppliers, or vendors&#59; internal personnel and financial information&#59; business and&#47;or personal information about any senior staff members of the Group or any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, association, joint-stock company, estate, trust, organization, governmental authority or other entity of any kind or nature (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with which the Group enters a strategic alliance or any other partnering arrangements&#59; vendor and supplier information&#59; the manner and method of conducting the Group&#8217;s business&#59; the identity or nature of relationship of any Persons associated with or engaged as consultants, advisers, agents, distributors or sales representatives (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) the disclosure of any of which to competitors of the Group or to the general public, or the use of same by the Executive or any competitor of the Group, would be highly detrimental to the interests of the Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">disclosure or use of Confidential Information, other than in connection with the Group&#8217;s business or as specifically authorized by the Group, will be highly detrimental to the business and interests of the Group and could result in serious loss of business and damage to it. Accordingly, the Executive specifically agrees to hold all Confidential Information in strictest confidence, and the Executive agrees that the Executive shall not, without the Company&#8217;s prior written consent, disclose, divulge or reveal to any Person, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">use for any purpose other than for the exclusive benefit of the Company, any Confidential Information, in whatever form contained&#59; provided that the foregoing shall not apply to information (except for personal information about identifiable individuals) that&#58; (i)&#160;was known to the public prior to its disclosure to the Executive&#59; (ii)&#160;becomes generally known to the public subsequent to disclosure to the Executive other than by reason of the Executive&#8217;s breach of this Section&#59; (iii)&#160;becomes available to the Executive from a source independent of the Group&#59; or (iv)&#160;the Executive is specifically required to disclose by applicable law or legal process (provided that, to the extent legally permissible, the Executive provides the Company with prompt advance written notice of the contemplated disclosure and cooperates with the Company in seeking a protective order or other appropriate protection of such information)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the Executive shall deliver to the Company, immediately upon termination of employment (for any reason and regardless of whether the Executive or the Company terminate the employment) or at any time the Company so requests&#58; (i)&#160;any and all documents, files, notes, memoranda, models, databases, computer files and&#47;or other computer programs reflecting any Confidential Information whatsoever or otherwise relating to the Group&#8217;s business&#59; (ii)&#160;lists or other documents regarding customers, suppliers, or vendors of the Group or leads or referrals to prospective business deals&#59; and (iii)&#160;any computer equipment, home office equipment, automobile or other business equipment belonging to the Company that the Executive may then possess or have under the Executive&#8217;s control.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">this agreement shall not limit the Executive&#8217;s rights under applicable law to initiate communications directly with, provide information to, respond to any inquiries from, or report possible violations of law or regulation to any governmental entity or self-regulatory authority, or participate in an investigation conducted by any governmental entity or self-regulatory authority, and the Executive does not need the Group&#8217;s permission to do so. In addition, it is understood that this Agreement shall not require the Executive to notify the Group of a request for information from any governmental entity or self-regulatory authority that is not directed to a member of the Group or of the Executive&#8217;s decision to file a charge or complaint with or participate in an investigation conducted by any governmental entity or self-regulatory authority. Notwithstanding the foregoing, the Executive recognizes that, in connection with the provision of information to any governmental entity or self-regulatory authority, the Executive must inform such governmental entity or self-regulatory authority that the information the Executive is providing is confidential. Despite the foregoing, the Executive is not permitted to reveal to any third party, including any governmental entity or self-regulatory authority, information the Executive comes to learn during the Executive&#8217;s service to the Company that is protected from disclosure by any applicable privilege, including but not limited to the attorney-client privilege or attorney work product doctrine. The Group does not waive any applicable privileges or the right to continue to protect its privileged attorney-client information, attorney work product, and other privileged information. The Executive is hereby notified that the U.S. Defend Trade Secrets Act of 2016, 18 U.S.C. &#167; 1833(b) provides that an individual cannot be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that is made&#58; (A) in confidence to federal, state or local government officials, either directly or indirectly, or to an attorney, and is solely for the purpose of reporting or investigating a suspected violation of the law&#59; (B) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal&#59; or (C) to the individual&#8217;s attorney in connection with a lawsuit for retaliation for reporting a suspected violation of law (and the trade secret may be used in the court proceedings for such lawsuit) as long as (x) any document containing the trade secret is filed under seal and (y) the trade secret is not disclosed except pursuant to court order. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Intellectual Property</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;In this Section 7.2, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Germplasm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any living or preserved biological tissue or material which may be used for the purpose of plant breeding and&#47;or propagation, including, plants, cuttings, seeds, clones, cells, tissues, plant materials and genetic materials (including nucleic acids, genes, promoters, reading frames, regulatory sequences, terminators, chromosomes whether artificial or natural and vectors).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For the purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any and all intellectual property rights and proprietary rights existing in any jurisdiction throughout the world, including any rights in or to&#58;  (i) patents, patent applications, patent rights, inventions, industrial designs, industrial design applications, industrial design rights, ideas, discoveries and invention disclosures (whether or not patentable), and any divisionals, continuations, continuations-in-part, reissues, renewals, reexaminations and extensions of any of the foregoing&#59; (ii) trademarks, service marks, trade names, trade dress, logos, packaging designs, slogans, other indicia of source, Internet domain names and URLs, and registrations and applications for registration of any of the foregoing and any renewals thereof, together with any goodwill symbolized thereby&#59; (iii) copyrightable works (including with respect to software and compilations of data), whether published or unpublished, including all copyrights, copyright registrations and applications&#59; (iv)&#160;trade secrets, and confidential or proprietary information, data or database rights, know-how, techniques, designs, processes, recipes and formulas&#59; (v) Germplasm, plant varieties, and applications and registrations for plant varieties issued by or pending before any Governmental Authority, including under the Plant Variety Protection Act (United States) or the Plant Breeders&#8217; Rights Act (Canada)&#59; and (vi) circuit topographies, database rights and software.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Executive agrees to promptly disclose to the Company (including, to the CEO) all Intellectual Property, including with respect to Germplasm, and whether or not any of the foregoing are registrable, which the Executive may author, make, conceive, develop, discover or reduce to practice, solely, jointly or in common with other employees, during the Executive&#8217;s employment with the Company, and which relate to the business activities of the Group (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive-Developed IP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). Intellectual Property coming within the scope of the business of the Company made and&#47;or developed by the Executive while in the employ of the Company, whether or not conceived or made during regular working hours and whether or not the Executive is specifically instructed to make or develop the same, shall be for the benefit of the Company and shall be considered to have been made pursuant to this Agreement and shall be deemed Executive-Developed IP and shall immediately become exclusive property of the Company. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Executive further acknowledges that all Executive-Developed IP is &#8220;work made for hire&#8221; (to the greatest extent permitted by applicable law), &#8220;made in the course of employment&#8221; and owned exclusively by the Company and that the Executive has been compensated for such Executive-Developed IP by the Executive&#8217;s salary, commissions and other benefits, unless regulated otherwise by law. To the extent such Executive-Developed IP is not &#8220;work made for hire&#8221;, &#8220;made in the course of employment&#8221; or otherwise not owned automatically and exclusively by the Company as a matter of law, then to the greatest extent permitted under by applicable law, the Executive hereby irrevocably assigns and transfers, and shall assign and transfer, to the Company, the Executive&#8217;s entire right, title and interest in and to any and all Executive-Developed IP, and the Executive agrees to execute and deliver to the Company any and all instruments </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">necessary or desirable to accomplish the foregoing and, in addition, to do all lawful acts which may be necessary or desirable to assist the Company to obtain and enforce protection of Executive-Developed IP. If and to the extent the foregoing assignment cannot be effected as a matter of law with respect to any Executive-Developed IP, the Executive hereby grants to the Company an exclusive, perpetual, fully-paid, royalty-free, irrevocable, worldwide, fully-transferable, fully sublicensable (on multiple levels) license to use, modify, display, perform, make, have made, copy, make derivative works, import, export, distribute and otherwise exploit such Executive-Developed IP for any purpose. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;The Executive must keep, maintain and make available to the Company complete and up-to-date records relating to any Executive-Developed IP, and agree that all such records are the sole and absolute property of the Company. For greater certainty, all materials related to Executive-Developed IP (including notes, records and correspondence, whether written or electronic) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Development Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) are the property of the Company, which the Executive shall provide to the Company upon request. Development Records shall not be removed from Company premises without the prior written consent of the Company. The Executive agrees to maintain as confidential any Executive-Developed IP and Development Records unless and until made generally public by the Company, and not to make application for registration of rights in respect of any Executive-Developed IP unless it is at the request and direction of the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;The Executive shall, at the request and cost of the Company, and for no additional compensation or consideration from the Company, sign, execute, make and do all such deeds, documents, acts and things as the Company and its duly authorized agents may reasonably require&#58; (i) to apply for, obtain and vest in the name of the Company alone (unless the Company otherwise directs) registered rights in any Executive-Developed IP, including any patents, industrial designs, letters patent, copyrights, plant breeders&#8217; rights, trademarks, service marks or other analogous protection in any country throughout the world and when so obtained or vested to renew and restore the same&#59; (ii)&#160;to perfect or evidence ownership by the Company or its designees of any and all Executive-Developed IP, in form suitable for recordation in the United States, Canada and any other intellectual property office anywhere in the world&#59; (iii) to defend any opposition proceedings of any type whatsoever in respect of such applications, and any opposition proceedings or petitions or applications of any type whatsoever for revocation of such Executive-Developed IP, whether such proceedings are brought before a court or any administrative body&#59; (iv) to defend and&#47;or assert the Group&#8217;s rights in any Intellectual Property against any third party&#59; and (v) to assert the Executive&#8217;s moral rights in any Intellectual Property against any third party. The Executive further waives all moral rights in and to any Executive-Developed IP and all work the Executive produced during the course of the Executive&#8217;s employment in favor of the Company, its licensees, successors and assigns, and transferees of the Executive-Developed IP and such work.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;If, in the course of performing duties pursuant to this Agreement, the Executive uses any Germplasm, the Executive shall only use Germplasm provided by the Company, and the Executive agrees that any such Germplasm provided by the Company remains the sole property of the Company and that such Germplasm shall not be removed from Company premises without the prior written consent of the Company. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;The Executive represents and warrants that the Executive does not possess any Intellectual Property or Germplasm of any third party, including any prior employer or competitor of the Group, and the Executive shall not acquire and&#47;or use Intellectual Property or Germplasm of any third party in the course of performing duties pursuant to this Agreement and shall not bring any Germplasm of any third party onto Company premises.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive shall not at any time during the Executive&#8217;s employment with the Company and for a period of one year following the termination of the Executive&#8217;s employment with the Company for any reason, either individually or in partnership or jointly or in conjunction with any Person as principal, agent, consultant, employee, partner, director,  shareholder (other than an investment of less than five percent of the shares of a company traded on a registered stock exchange or traded in the over the counter market in the United States or Canada), or in any other capacity whatsoever&#58;  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">engage in employment or enter into a contract to do work related to the research into, development, cultivation, production, supply, sales or marketing of cannabis or cannabis derived products&#59; or the development or provision of any services (including technical and product support, or consultancy or customer services) which relate to cannabis or cannabis derived products (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">have any financial or other interest (including by way of royalty or other compensation arrangements) in or in respect of the business of any Person which carries on the Business in any respect&#59; or </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">advise, lend money to or guarantee the debts or obligations of any Person which carries on the Business in any respect&#59;  </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt">anywhere within Canada and&#47;or the United States of America.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt">For purposes of this section, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">cannabis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means (a) any plant or seed, whether live or dead, from any species or subspecies of genus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis sativa</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis indica</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis ruderalis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, marijuana (which has the meaning ascribed to such term under applicable law, including the Controlled Substances Act) and industrial hemp (which has the meaning ascribed to such term and the term &#8220;hemp&#8221; under applicable law, including the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Industrial Hemp Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (Canada) issued under the Cannabis Act and under the Agricultural Marketing Act of 1946) and any part, whether live or dead, of the plant or seed thereof, including any stalk, branch, root, leaf, flower, or trichome&#59; (b) any material obtained, extracted, isolated, or purified from the plant or seed or the parts contemplated by clause (a) of this definition, including any oil, cannabinoid, terpene, genetic material or any combination thereof&#59; (c) any organism engineered to biosynthetically produce the material contemplated by clause (b) of this definition, including any micro-organism engineered for such purpose&#59; (d) any biologically or chemically synthesized version of the material contemplated by clause (b) of this definition or any analog thereof, including any product made by any organism contemplated by clause (c) of this definition&#59; and (e) any other meaning ascribed to the term &#8220;cannabis&#8221; under applicable law, including the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Controlled Drugs and Substances Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Non-Solicitation of Customers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive shall not, during the Executive&#8217;s employment and for the one year period immediately following the termination of the Executive&#8217;s employment for any reason, whether alone or for or in conjunction with any Person, whether as an employee, partner, director, principal, agent, consultant or in any other capacity whatsoever, directly or indirectly solicit or attempt to solicit any Customer or Prospective Customer for the purpose of obtaining the business of any Customer or Prospective Customer or persuading any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such Customer or Prospective Customer to cease to do business with or reduce the amount of business it would otherwise provide to the Group. For the purpose of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person which is a current customer or has been a customer of the Group during the term of the Executive&#8217;s employment with the Company but in the event of the cessation of the Executive&#8217;s employment &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall include only those current customers of the Group with whom the Executive had direct contact or access to Confidential Information by virtue of the Executive&#8217;s role as an employee of the Company at any time during the twelve month period preceding the date of the cessation of the Executive&#8217;s employment&#59; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">direct contact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means direct communications with or by the Executive, whether in person or otherwise, for purposes of servicing, selling, or marketing on behalf of the Company, but only if such communications are more than trivial in nature, and in any case excluding bulk or mass marketing communications directed to multiple customers&#59; and, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Prospective Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person has been actively contacted and solicited for its business by representatives of the Group, but in the event of the cessation of the Executive&#8217;s employment, shall include only those Persons contacted with the involvement and knowledge of the Executive within the twelve month period immediately preceding the date of the cessation of the Executive&#8217;s employment. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Non-Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive shall not, during the Executive&#8217;s employment and for two years following the termination of the Executive&#8217;s employment for any reason, whether alone or for or in conjunction with any Person, whether as an employee, partner, director, principal, agent, consultant or in any other capacity whatsoever, directly or indirectly solicit or assist in the solicitation of any employee of the Group to leave such employment. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. During the Executive&#8217;s employment with the Company, the Executive shall promptly disclose to the Board full information concerning any interest, direct or indirect, of the Executive (whether as owner, shareholder, partner, lender or other investor, director, officer, employee, consultant or otherwise) or any member of the Executive&#8217;s immediate family, in any business which is reasonably known to the Executive to purchase or otherwise obtain services or products from, or to sell or otherwise provide services or products to the Group or to any of their respective suppliers or Customers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Other Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">During the Executive&#8217;s employment with the Company, the Executive shall not, except as a representative of the Company or with the prior written approval of the CEO, whether paid or unpaid, be directly or indirectly engaged, concerned or have any financial interest in any capacity in any other business, trade, professional or occupation (or the setting up of any business, trade, profession or occupation).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Return of Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. All files, forms, brochures, books, materials, written correspondence (including email and instant messages), memoranda, documents, manuals, computer disks, software products and lists (including financial and other information and lists of customers, suppliers, products and prices) pertaining to the Group which may come into the Executive&#8217;s possession or control shall at all times remain the property of the Group as applicable. Upon termination of the Executive&#8217;s employment for any reason, the Executive agrees to immediately deliver to the Company all such property in the Executive&#8217;s possession or directly or indirectly under the Executive&#8217;s control. The Executive agrees not to make, for the Executive&#8217;s personal or business use or that of any other person, reproductions or copies of any such property or other property of the Group.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Non-Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to Section 7.1(d), the Executive shall refrain, both during and after the cessation of the Executive&#8217;s employment with the Company, from making, publicly or privately, any statement or announcement that constitutes an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">ad hominem</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attack on, or that otherwise disparages, defames, slanders, impugns or is reasonably likely to damage the reputation of&#160;the Company or the Group, or any of their respective directors, members, limited or general partners, equity holders, officers, employees, agents, consultants, advisors or other representatives.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">General</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Reasonableness of Restrictions and Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive hereby confirms and agrees that the covenants and restrictions contained in this Agreement, including those contained in Article&#160;7, are reasonable and valid the Executive further acknowledges and agrees that the Company may suffer irreparable injury in the event of any breach by the Executive of the obligations under any such covenant or restriction. Accordingly, the Executive hereby acknowledges and agrees that damages would be an inadequate remedy at law in connection with any such breach and that the Company shall therefore be entitled, in addition to any other right or remedy which it may have at law, in equity or otherwise, to temporary and permanent injunctive relief enjoining and restraining the Executive from any such breach.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article 7 and this Section 8.2 survive the termination of this Agreement and the Executive&#8217;s employment for any reason whatsoever. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement (including the exhibits hereto) sets forth the entire agreement between the Parties on the subject matters addressed herein. There are no representations, warranties or collateral agreements, whether written or oral, outside of this written Agreement. This Agreement and the terms and conditions of employment contained herein supersede and replace any prior understandings or discussions between the Parties, including the Original Agreement, regarding the Executive&#8217;s employment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may deduct or withhold from any amounts or benefits payable under this Agreement income taxes and payroll taxes that are required to be withheld pursuant to any applicable law or regulation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. To the extent applicable, this Agreement is intended to comply with the requirements of Section 409A (together with the applicable regulations thereunder, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of the United States Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). To the extent that any provision in this Agreement is ambiguous as to its compliance with Section 409A or to the extent any provision in this Agreement must be modified to comply with Section 409A (including Treasury Regulation 1.409A-3(c)), such provision shall be read, or shall be modified (with the mutual consent of the Parties, which consent shall not be unreasonably withheld), as the case may be, in such a manner so that all payments due under this Agreement shall comply with Section 409A. For purposes of Section 409A, each payment made under this Agreement shall be treated as a separate payment. In no event may the Executive, directly or indirectly, designate the calendar year of payment. Notwithstanding any provision of this Agreement to the contrary, if necessary to comply with the restriction in Section 409A(a)(2)(B) concerning payments to &#8220;specified employees&#8221; (as defined in Section 409A) any payment on account of the Executive&#8217;s separation from service that would otherwise be due hereunder within six months after such separation shall nonetheless be delayed until the first business day of the seventh month following the Executive&#8217;s date of termination and the first such payment shall include the cumulative amount of any payments that would have been paid prior to such date if not for such restriction. Notwithstanding anything contained herein to the contrary, the Executive shall not be considered to have terminated employment with the Company for purposes of this Agreement unless she would be considered to have incurred a &#8220;separation from service&#8221; from the Company within the meaning of Section 409A. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Section 280G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event that any payment or benefit that the Executive would receive from the Company or otherwise in connection with a change of control or other similar transaction (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">280G Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (i) would constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G of the Code and (ii) but for this Section 8.6, would be subject to the excise tax imposed by Section 4999 of the Code, then any such 280G Payment shall be payable either (a) in full, or (b) as to such lesser amount which would result in no portion of such payments and benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of payments and benefits notwithstanding that all or some portion of such payments and benefits </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">may be taxable under Section 4999 of the Code. If a reduced amount is to be paid under this Section 6.1, reductions in payments and&#47;or benefits shall occur in the following order&#58; (1) if none of the payments is nonqualified deferred compensation under Section 409A, then the reduction shall occur in the manner the Executive elects in writing prior to the date of payment and (2) if any payment constitutes nonqualified deferred compensation under Section 409A or if the Executive fails to elect an order, then the payments to be reduced shall be determined in a manner which has the least economic cost to Executive and, to the extent the economic cost is equivalent, shall be reduced in the inverse order of when payment would have been made to Executive, until the reduction is achieved&#59; provided, however, that no such reduction or elimination shall apply to any non-qualified deferred compensation amounts (within the meaning of Section 409A) to the extent such reduction or elimination would accelerate or defer the timing of such payment in manner that does not comply with Section 409A. All determinations required to be made under this paragraph, including the manner and amount of any reduction in Executive&#8217;s payments hereunder, and the assumptions to be utilized in arriving at such determinations, shall be made in writing in good faith by a nationally recognized accounting or consulting firm selected by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement may only be amended by written agreement executed by the Parties. However, for the avoidance of doubt, changes to the Executive&#8217;s position, duties, vacation, benefits and compensation, over time in the normal course, do not affect the validity or enforceability of the Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware and the laws of the United States applicable in the State of Delaware. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If any provision in this Agreement is determined to be invalid or unenforceable, such provision shall be severed from this Agreement, and the remaining provisions shall continue in full force and effect. If for any reason any court of competent jurisdiction shall find any provisions of this Agreement unreasonable in duration or geographic scope or otherwise, the Parties agree that the restrictions and prohibitions contained herein shall be effective to the fullest extent allowed under applicable law in such jurisdiction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may assign this Agreement to an affiliate or subsidiary, and it inures to the benefit of the Company, its successors or assigns.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Independent Legal Advice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Executive acknowledges that the Executive has been encouraged to obtain independent legal advice regarding the execution of this Agreement, and that the Executive has either obtained such advice or voluntarily chosen not to do so, and hereby waives any objections or claims the Executive may make resulting from any failure on the Executive&#8217;s part to obtain such advice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> No waiver of any of the provisions of this Agreement shall be effective or binding, unless made in writing and signed by the party purporting to give the same. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions, whether or not similar, nor shall such waiver constitute a continuing waiver, unless expressly stated otherwise. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement and the Executive&#8217;s continued employment hereunder is conditional on the Company&#8217;s satisfaction (determined in the Company&#8217;s sole discretion) that the Executive has met the legal requirements to perform the Executive&#8217;s role, including satisfactory results of Health Canada or any other applicable security clearance checks and criminal record checks and other reference checks that the Company performs. The Executive acknowledges and agrees that in signing this Agreement, and providing the Company with the necessary documentation to perform the checks required for the Executive&#8217;s role and with references, the Executive is providing consent to the Company or its agent, to performs such checks and contact the references the Executive provided to the Company. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Prior Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. By signing below, the Executive represents and warrants that the Executive is not bound by the terms of any agreement with any Person which restricts in any way the Executive&#8217;s hiring by the Company and the performance of the Executive&#8217;s expected job duties&#59; the Executive also represents and warrants that, during the Executive&#8217;s employment with the Company, the Executive shall not disclose or make use of any confidential information of any other persons or entities in violation of any of their applicable policies or agreements and&#47;or applicable law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Certain Rules of Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All Section titles or other captions in this Agreement are for convenience only, and they shall not be deemed part of this Agreement and in no way define, limit, extend or describe the scope or intent of any provisions hereof. Unless the context otherwise requires&#58; (a)&#160;&#8220;herein&#8221;, &#8220;hereof&#8221; and other words of similar import refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement&#59; (b)&#160;all references to &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; refer to clauses or Sections of this Agreement&#59; (c)&#160;all references to &#8220;including&#8221; or any variation thereof shall be construed as meaning &#8220;including, without limitation&#8221;&#59; and (d) references to &#8220;Exhibits&#8221; or &#8220;Schedules&#8221; refer to the Exhibits and Schedules attached to this Agreement, each of which is made a part hereof for all purposes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement may be executed in one or more counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by electronic transmission, including in portable document format (.pdf), shall be deemed as effective as delivery of an original executed counterpart of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page Follows&#93;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> this Agreement has been executed by the Parties as of this 19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> day of March, 2025.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CRONOS USA CLIENT SERVICES LLC</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cronos Group Inc., its sole member</font></div><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:3.12pt;padding-right:3.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Michael Gorenstein</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-42.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Michael Gorenstein</font></div><div style="padding-right:-4.83pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Chairman, President and Chief      Executive Officer</font></div></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CRONOS GROUP INC.<br></font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Michael Gorenstein</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-42.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Michael Gorenstein</font></div><div style="padding-right:-9.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Chairman, President and Chief Executive Officer&#160;&#160;&#160;&#160;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ANNA SHLIMAK</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt;padding-left:3.12pt;padding-right:3.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Anna Shlimak</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-42.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58; March 19, 2025&#160;&#160;&#160;&#160;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:3.12pt;padding-right:3.12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.12pt;padding-right:3.12pt;text-indent:-36pt"><font><br></font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">EXHIBIT A<br>FORM OF FULL AND FINAL RELEASE</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GENERAL RELEASE AND WAIVER OF CLAIMS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), by the undersigned</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Releasor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in favor of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos Group, Inc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and its subsidiaries (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), affiliates, stockholders, beneficial owners of its stock, its current or former officers, directors, employees, members, attorneys and agents, and their predecessors, successors and assigns, individually and in their official capacities (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor has been employed as Chief Financial Officer of Cronos Group, Inc.&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor&#8217;s employment with Cronos USA Client Services LLC was terminated, effective as of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#9679; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor is seeking certain payments under Section 6.3 of the employment agreement entered into by Cronos USA Client Services LLC, the Releasor and, solely for the purposes specified therein, Cronos Group, Inc., effective March 19, 2025 (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), that are conditioned on the effectiveness of this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOW, THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in consideration of such payments and benefits and the covenants and agreements hereinafter set forth, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">GENERAL RELEASE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Releasor knowingly and voluntarily waives, terminates, cancels, releases and discharges forever the Releasees from any and all suits, actions, causes of action, claims, allegations, rights, obligations, liabilities, demands, entitlements or charges (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) that Releasor (or Releasor&#8217;s heirs, executors, administrators, successors and assigns) has or may have, whether known, unknown or unforeseen, vested or contingent, by reason of any matter, cause or thing occurring at any time before and including the date of this Release, including all claims arising under or in connection with Releasor&#8217;s employment, or termination or resignation of employment with the Employer, including&#58;  Claims under United States federal, state or local law and the national or local law of any foreign country (statutory or decisional), for wrongful, abusive, constructive or unlawful discharge or dismissal, for breach of any contract, or for discrimination based upon race, color, ethnicity, sex, age, national origin, religion, disability, sexual orientation, or any other unlawful criterion or circumstance, including rights or Claims under the Age Discrimination in Employment Act of 1967 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Older Workers Benefit Protection Act of 1990 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OWBPA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), violations of the Equal Pay Act, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Americans with Disabilities Act of 1991, the Employee Retirement Income Security Act of 1974 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Fair Labor Standards Act, the Worker Adjustment Retraining and Notification Act, the Family Medical Leave Act, including all amendments to any of the aforementioned acts&#59; and violations of any other federal, state, or municipal fair employment statutes or laws, including violations of any other law, rule, regulation, or ordinance pertaining to employment, wages, compensation, hours worked, or any other Claims for compensation or bonuses, whether or not paid under any compensation plan or arrangement&#59; breach of contract&#59; tort and other common law Claims&#59; defamation&#59; libel&#59; slander&#59; impairment of economic opportunity defamation&#59; sexual harassment&#59; retaliation&#59; attorneys&#8217; fees&#59; emotional distress&#59; intentional infliction of emotional distress&#59; assault&#59; battery, pain and suffering&#59; and punitive or exemplary damages (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Released Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  In addition, in consideration of the provisions of this Release, Releasor further agrees to waive any and all rights under the laws of any jurisdiction in the United States, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or any other country, that limit a general release to those Claims that are known or suspected to exist in Releasor&#8217;s favor as of the Release Effective Date (as defined below).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Thus, notwithstanding the purpose of implementing a full and complete release and discharge of the claims released by this Release, Releasor expressly acknowledges that this Release is intended to include in its effect all claims which Releasor does not know or suspect to exist in his favor at the time of execution hereof arising out of or relating in any way to the subject matter of the actions referred to herein above and that this Release contemplates the extinguishment of any such claims.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">SURVIVING CLAIMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything herein, in your Employment Agreement, or in that certain letter agreement, effective as of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#9679; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">between Releasor and Employer to the contrary, this Release shall not&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:7.63pt">release any Claims for payment of amounts payable under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Employment Agreement (including under Section 6.3 thereof)&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:4.58pt">release any Claim for employee benefits under plans covered by ERISA to the extent any such Claim may not lawfully be waived or for any payments or benefits under any Employer plans that have vested (including any 401(k) plan) according to the terms of those plans&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:1.53pt">release any Claim or right Releasor may have pursuant to indemnification, advancement, defense, or reimbursement pursuant to any applicable D&#38;O policies, any similar insurance policies, applicable law or otherwise&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:2.13pt">release any Claim that may not lawfully be waived in a private agreement between the parties&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">prohibit or restrict Releasor from (A) participating, cooperating, testifying, or expressing an interest in doing any of the same, in any action, review, investigation, or proceeding by, or providing information or documents to, any government or regulatory agency or authority, including the U.S. Securities and Exchange Commission and the Ontario Securities Commission, (B) accepting monetary awards or other incentives for participating in a whistleblower program administered by any government or regulatory agency or authority, including the U.S. Securities and Exchange Commission or the Ontario Securities Commission, (C) making disclosures under the whistleblower provisions of applicable Canadian federal, Canadian provincial, U.S. federal or U.S. state law or regulation (including Section 21F of the Securities Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002), or (D) making a complaint to, initiating communications with, or responding to any inquiry from, any government or regulatory agency or authority, including the U.S. Securities and Exchange Commission and the Ontario Securities Commission, regarding any good faith concerns about possible violations of law or regulation. Releasor does not need prior authorization from any Releasees to make any such reports or disclosures and Releasor is not required to notify any Releases that such reports or disclosures have been made. Despite the foregoing, Releasor is not permitted to reveal to any third party, including any government or regulatory agency or authority, information Releasor came to learn during Releasor&#8217;s service to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Employer that is protected from disclosure by any applicable privilege, including but not limited to the attorney-client privilege or attorney work product doctrine.  The Employer does not waive any applicable privileges or the right to continue to protect its privileged attorney-client information, attorney work product, and other privileged information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">ADDITIONAL REPRESENTATIONS AND WARRANTIES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor further represents and warrants that Releasor has not filed any civil action, suit, arbitration, administrative charge, or legal proceeding against any Releasees nor, has Releasor assigned, pledged, or hypothecated as of the Release Effective Date any Claim to any person and no other person has an interest in the Claims that she is releasing.  However, this representation does not apply to any charges, actions, or proceedings before, or engaging in communications with, the U.S. Securities and Exchange Commission or the Ontario Securities Commission about possible fraud or other securities law violations occurring prior to the date you execute this agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">ACKNOWLEDGMENT BY RELEASOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor acknowledges and agrees that Releasor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">has read this Release in its entirety and that this Release is a general release of all known and unknown Claims.  Releasor further acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:7.63pt">this Release does not release, waive or discharge any rights or Claims that may arise for actions or omissions after the Release Effective Date and Releasor acknowledges that she is not releasing, waiving or discharging any ADEA Claims that may arise after the Release Effective Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:4.58pt">Releasor is entering into this Release and releasing, waiving and discharging rights or Claims only in exchange for consideration which she is not already entitled to receive&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:1.53pt">Releasor has been advised, and is being advised by the Release, to consult with an attorney before executing this Release&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:2.13pt">Releasor has been advised, and is being advised by this Release, that she has been given at least </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">twenty-one (21)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93; &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">forty-five (45)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> days within which to consider the Release, but Releasor can execute this Release at any time prior to the expiration of such review period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:5.18pt">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Because this Release includes a release of claims under ADEA, Releasor is being provided with the information contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereto in accordance with the OWBPA&#59; and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:2.13pt">Releasor is aware that this Release shall become null and void if she or she revokes his or her agreement to this Release within seven (7) days following the date of execution of this Release.  Releasor may revoke this Release at any time during such seven-day period by delivering (or causing to be delivered) to the Employer written notice of his or her revocation of this Release no later than 5&#58;00 p.m. Eastern time on the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) full day following the date of execution of this Release (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Release Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Releasor agrees and acknowledges </font></div><div style="border-bottom:0.5pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:144pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.82pt;font-weight:400;line-height:120%;position:relative;top:-3.67pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Note to Draft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#58;  To be included (along with 45 day consideration period and Schedule 1 attached hereto) in consideration for ADEA&#47;OWBPA claims in terminations involving multiple employees.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that a letter of revocation that is not received by such date and time shall be invalid and shall not revoke this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">COOPERATION WITH INVESTIGATIONS AND LITIGATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Releasor agrees, upon the Employer&#8217;s reasonable request and consistent with Releasor&#8217;s reasonable business and personal obligations, to reasonably cooperate with the Employer in any investigation, litigation, arbitration or regulatory proceeding regarding events that occurred during Releasor&#8217;s tenure with the Employer or its affiliate, including making himself or herself reasonably available to consult with Employer&#8217;s counsel, to provide information and to give testimony.  Employer shall reimburse Releasor for reasonable out-of-pocket expenses Releasor incurs in extending such cooperation, so long as Releasor provides satisfactory documentation of the expenses.  Nothing in this Section is intended to, and shall not, restrict or limit Releasor from exercising his or her protected rights described in Sections 2, 4, 5 or 6 hereof or restrict or limit Releasor from providing truthful information in response to a subpoena, other legal process or valid governmental inquiry.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">RESTRICTIVE COVENANTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Releasor hereby affirms the restrictive covenants set forth in Section 7 of the Employment Agreement shall continue to apply following the Release Effective Date in accordance with their terms, subject to Releasor&#8217;s protected rights as set forth in Section 2(v) of this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  To the extent not subject to federal law, this Release shall be governed by and construed in accordance with the law of the State of Delaware applicable to contracts made and to be performed entirely within that state.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">SEVERABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If any provision of this Release should be declared to be unenforceable by any administrative agency or court of law, then remainder of the Release shall remain in full force and effect.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">CAPTIONS&#59; SECTION HEADINGS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Captions and section headings used herein are for convenience only and are not a part of this Release and shall not be used in construing it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">COUNTERPARTS&#59; FACSIMILE SIGNATURES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Release may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original instrument without the production of any other counterpart.  Any signature on this Release, delivered by either party by photographic, facsimile or PDF shall be deemed to be an original signature thereto.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> I have hereunder set my hand this _______ day of ___________, 20____.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNED AND DELIVERED</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the presence of&#58;</font></div><div style="margin-top:36pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Witness&#8217; Signature</font></div><div style="margin-top:36pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Print Name of Witness</font></div><div style="margin-top:36pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address of Witness</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:30pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:6.37pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name of Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 1</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;TO BE COMPLETED AND PROVIDED IF APPLICABLE&#93;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As required by the Older Workers Benefit Protection Act, the Employer is providing the following information.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;To respect the privacy of your colleagues, we ask that you use the information on this Schedule only for its intended purpose &#8211; to help you decide whether to enter into the Release &#8211; and that you otherwise treat this information as confidential.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All employees of the Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">describe subset of employees considered for separation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (known as the &#8220;decisional unit&#8221;) were considered for the separation program.  The chart below shows the job titles and ages, as of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#9679;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, of each employee in the decisional unit and whether or not such employee has been selected for termination and offered separation pay in exchange for signing a release under the separation program.  Employees have 45 days to consider whether to sign and 7 days to revoke any such release.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Job Title</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Age<br>(as of &#9679;)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Selected for the separation program&#63;</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">22</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102-holmseparationa.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i1ce9287586a34d7f92a7cd8c3efc19ee_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXHIBIT 10.2</font></div></div><div style="margin-bottom:12pt;margin-top:60pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">March 19, 2025</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">James Holm</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At the Address on file with the Company</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dear James,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This letter agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), effective as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), sets forth the terms and conditions of our agreement regarding your resignation from your employment with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and wholly owned subsidiary of Cronos Group Inc., a corporation organized under the laws of the Province of British Columbia (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Cronos Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Unless context otherwise requires, capitalized terms used in this Letter Agreement that are not defined herein have the meanings set forth in the Employment Agreement between you, the Company and solely for the purposes specified therein, Cronos Group, dated as of November 14, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Separation</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Your employment with the Company will cease on April 18, 2025 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Separation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  From the Effective Date to the Separation Date&#58; (a) you will continue to be employed by the Company but shall cease to serve as Chief Financial Officer of Cronos Group, (b) you will not perform any work for the Company except responding to inquiries in a timely manner to facilitate the transition of your duties and responsibilities&#59; and (c) the Company may in good faith reassign or reduce your duties and responsibilities.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">As of the Effective Date, you voluntarily and irrevocably resign from all positions you hold as an officer or director (or similar or equivalent position) of the Company, Cronos Group or any subsidiary thereof (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Resignations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  The Company and Cronos Group hereby accept, acknowledge and agree to the Resignations.  If any other documentation is necessary to properly effectuate the Resignations, you agree to cooperate reasonably and promptly in executing and delivering it at the request of the Company or Cronos Group.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Company shall&#58; (i) pay your Base Salary for the period up to the Separation Date&#59; and (ii) reimburse your documented expenses properly incurred prior to the Effective Date in accordance with the Company&#8217;s expense reimbursement policy.  Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of this Letter Agreement, your participation in the Company&#8217;s benefit plans shall end on the Separation Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Contingent on your execution and non-revocation of the Release and Waiver of Claims attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) on or following the Separation Date in accordance with the timing set forth therein, and subject to&#58; (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of this Letter Agreement&#59; and (ii) your compliance with the terms and conditions of this Letter Agreement and the post-employment obligations set forth in Article 7 of the Employment Agreement, including, without limitation, as relates to non-competition, non-solicitation, confidentiality, intellectual property, and return of property, in consideration of amounts in excess of the minimum entitlements under applicable law&#58;  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the Company shall, in full satisfaction of its obligations to you, </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.2pt">pay you US $385,000, which represents one (1) year of your annual base salary, payable by way of lump sum payment within thirty (30) days after the Separation Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.15pt">pay you US $20,260, which is equal to one year of the employer portion of your benefits premiums, to cover some of the costs of continuing your group insured benefits, should you decide to do so after the Separation Date&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.1pt">provide you an annual cash award in respect of the 2025 fiscal year (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) of US $104,046.25 comprised of an individual performance component equal to US $37,633.75 and a business performance component equal to US $442,750 multiplied by 60% (i.e., 0.6), and thereafter multiplied by a fraction where the numerator is (3) and the denominator is (12).  The Bonus shall be&#160;paid on the same date on which awards under STIC Program are provided to other Cronos Group executive officers in respect of the 2025 fiscal year. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">Cronos Group shall, in full satisfaction of its obligations to you, accelerate the vesting of 49,852 non-qualified stock options pursuant to Section 5(b)(iii) of your Option Award Agreement entered into on November 28, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Option Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Any vested options must be exercised in accordance with the terms and conditions of the applicable equity award plan and the Option Award Agreement by October 18, 2025. For the avoidance of doubt, except as set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, your entitlements in respect of any equity-based awards shall be governed by the terms and conditions of the applicable equity award plan and the applicable award agreements. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand and agree that the entitlements under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> are provided in satisfaction of your entitlements to notice of termination, pay in lieu of notice, termination pay, and severance pay under the Employment Agreement, any employee benefit plan sponsored by the Company or any of its affiliates, applicable law or otherwise.  You shall not be entitled to any other payments or benefits under the Employment Agreement, except as specifically provided herein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand and agree that any cash, equity or equity-based compensation paid or provided pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of this Letter Agreement is subject to the terms and conditions of Cronos Group&#8217;s Clawback Policy in effect from time to time, and may be subject to a requirement that such compensation be repaid to the Company after it has been distributed to you.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Restrictive Covenants&#59; Return of Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You hereby affirm that the restrictive covenants and other post-employment obligations contained in the Employment Agreement are and shall remain in effect and enforceable in accordance with the terms of the Employment Agreement, and you hereby reaffirm the existence and reasonableness of those obligations (including, without limitation, any non-disclosure and non-disparagement obligations, and any non-competition, and non-solicitation restrictions).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Cooperation with Litigation, Investigations and Regulatory Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You agree, upon the Company&#8217;s request, to cooperate with the Company in any investigation, litigation, arbitration or regulatory proceeding involving or relating to the Company or its affiliates, including by making yourself reasonably available to consult with the Company&#8217;s counsel.  The Company shall reimburse you for reasonable out-of-pocket expenses that you incur in extending such cooperation, so long as you provide satisfactory documentation of the expenses.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cronos Group hereby affirms that the Indemnity Agreement between you and Cronos Group shall remain in effect in accordance with its terms following the Separation Date, including with respect to maintenance of directors&#8217; and officers&#8217; liability insurance in accordance with the terms of the Indemnity Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Deductions and Withholdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand and agree that the Company shall make such deductions and withholdings from your remuneration and any other payments or benefits provided to you pursuant to this Letter Agreement as may be required by law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Letter Agreement may only be amended by written agreement executed by the Company, Cronos Group and you.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Independent Legal Advice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You acknowledge that you have been encouraged to obtain independent legal advice regarding the execution of this Letter Agreement, and that you have obtained such advice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.75pt;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All costs, fees and expenses incurred in connection with this Letter Agreement and the transactions contemplated by this Letter Agreement including all costs, fees and expenses of representatives of the parties hereto, shall be paid by the party incurring such cost, fee or expense. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:4.25pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Letter Agreement may be executed in one or more counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.  Delivery of an executed counterpart of a signature page to this Letter Agreement by electronic transmission, including in portable document format (.pdf), shall be deemed as effective as delivery of an original executed counterpart of this Letter Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font></div></div></div><div id="i1ce9287586a34d7f92a7cd8c3efc19ee_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If you agree that this Letter Agreement correctly memorializes our understandings, please sign and return this Letter Agreement, which shall become a binding agreement as of the Effective Date.</font></div><div style="margin-bottom:12pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="margin-bottom:48pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS GROUP INC.</font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Mike Gorenstein&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Name&#58;&#160;&#160;&#160;&#160;Mike Gorenstein<br>Title&#58;&#160;&#160;&#160;&#160;President, Chief Executive Officer and Chairman of the Board of Directors</font></div><div style="padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS USA CLIENT SERVICES LLC</font></div><div style="margin-bottom:48pt;margin-top:24pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;Cronos Group Inc., its sole member</font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Mike Gorenstein&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Name&#58;&#160;&#160;&#160;&#160;Mike Gorenstein<br>Title&#58;&#160;&#160;&#160;&#160;President, Chief Executive Officer and Chairman of the Board of Directors</font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:288pt;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:48pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accepted and Agreed&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; James Holm&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">James Holm</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58; March 19, 2025</font></div><div><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"></font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font></div></div></div><div id="i1ce9287586a34d7f92a7cd8c3efc19ee_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit A</font></div><div><font><br></font></div><div style="padding-left:288pt;padding-right:288pt;text-align:center;text-indent:-576pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FULL AND FINAL RELEASE AND WAIVER OF CLAIMS</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GENERAL RELEASE AND WAIVER OF CLAIMS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), by the undersigned</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Releasor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in favor of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos Group Inc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and its subsidiaries, including Cronos USA Client Services LLC (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), affiliates, stockholders, beneficial owners of its stock, its current or former officers, directors, employees, members, attorneys and agents, and their predecessors, successors and assigns, individually and in their official capacities (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor was employed as Chief Financial Officer of Cronos Group Inc.&#59; </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor&#8217;s employment with Cronos USA Client Services LLC ended effective as of April 18, 2025&#59; and </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor is seeking certain payments under Section 6.3 of the Employment Agreement entered into by Cronos USA Client Services LLC, the Releasor and, solely for the purposes specified therein, Cronos Group, Inc., dated November 14, 2022 (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), as set forth in the Letter Agreement between Employer, Cronos USA Client Services LLC and Releasor dated March 19, 2025 (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), that are conditioned on the effectiveness of this Release.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOW, THEREFORE,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in consideration of such payments and benefits and the covenants and agreements set forth in the Letter Agreement, the parties agree as follows&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">GENERAL RELEASE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor knowingly and voluntarily waives, terminates, cancels, releases and discharges forever the Releasees from any and all suits, actions, causes of action, claims, allegations, rights, obligations, liabilities, demands, entitlements or charges (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) that Releasor (or Releasor&#8217;s heirs, executors, administrators, successors and assigns) has or may have, whether known, unknown or unforeseen, vested or contingent, by reason of any matter, cause or thing occurring at any time before and including the date of this Release, including all claims arising under or in connection with Releasor&#8217;s employment, or termination or resignation of employment with the Employer, including, without limitation&#58;  Claims under United States federal, state or local law and the national or local law of any foreign country (statutory or decisional), for wrongful, abusive, constructive or unlawful discharge or dismissal, for breach of any contract, or for discrimination based upon race, color, ethnicity, sex, age, national origin, religion, disability, sexual orientation, or any other unlawful criterion or circumstance, including rights or Claims under the Age Discrimination in Employment Act of 1967 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Older Workers Benefit Protection Act of 1990 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OWBPA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), violations of the Equal Pay Act, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Americans with Disabilities Act of 1991, the Employee Retirement Income Security Act of 1974 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Fair Labor Standards Act, the Worker Adjustment Retraining and Notification Act, the Family Medical Leave Act, including all amendments to any of the aforementioned acts&#59; and violations of any other federal, state, or municipal fair employment statutes or laws, including, without limitation, violations of any other law, rule, regulation, or ordinance pertaining to employment, wages, compensation, hours worked, or any other Claims for compensation or bonuses, whether or not paid under any compensation plan or arrangement&#59; breach of contract&#59; tort and other common law Claims&#59; defamation&#59; libel&#59; slander&#59; impairment of economic opportunity defamation&#59; sexual harassment&#59; retaliation&#59; attorneys&#8217; fees&#59; emotional distress&#59; intentional infliction of emotional distress&#59; assault&#59; battery, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"></font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">pain and suffering&#59; and punitive or exemplary damages (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Released Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  In addition, in consideration of the provisions of this Release, Releasor further agrees to waive any and all rights under the laws of any jurisdiction in the United States, or any other country, that limit a general release to those Claims that are known or suspected to exist in Releasor&#8217;s favor as of the Release Effective Date (as defined below).</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Thus, notwithstanding the purpose of implementing a full and complete release and discharge of the claims released by this Release, Releasor expressly acknowledges that this Release is intended to include in its effect, without limitation, all claims which Releasor does not know or suspect to exist in his favor at the time of execution hereof arising out of or relating in any way to the subject matter of the actions referred to herein above and that this Release contemplates the extinguishment of any such claims.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">SURVIVING CLAIMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything herein, in your Employment Agreement or in the Letter Agreement, dated March 19, 2025, between Releasor and Employer to the contrary, this Release shall not&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:7.63pt">release any Claims for payment of amounts payable under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Letter Agreement (including, without limitation, under Section 2 thereof)&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:4.58pt">limit your right to elect to continue group health benefits pursuant to the Consolidated Omnibus Budget Reconciliation Act (COBRA)&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:1.53pt">release any Claim for employee benefits under plans covered by ERISA to the extent any such Claim may not lawfully be waived or for any payments or benefits under any Employer plans that have vested (including any 401(k) plan) according to the terms of those plans&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:2.13pt">release any Claim or right Releasor may have pursuant to indemnification, advancement, defense, or reimbursement pursuant to any applicable D&#38;O policies, any similar insurance policies, applicable law or otherwise&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">release any Claim that may not lawfully be waived in a private agreement between the parties&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:2.13pt">prohibit or restrict Releasor from (A) participating, cooperating, testifying, or expressing an interest in doing any of the same, in any action, review, investigation, or proceeding by, or providing information or documents to, any government or regulatory agency or authority, including the U.S. Securities and Exchange Commission and the Ontario Securities Commission, (B) accepting monetary awards or other incentives for participating in a whistleblower program administered by any government or regulatory agency or authority, including the U.S. Securities and Exchange Commission or the Ontario Securities Commission, (C) making disclosures under the whistleblower provisions of applicable Canadian federal, Canadian provincial, U.S. federal or U.S. state law or regulation (including Section 21F of the Securities Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002), or (D) making a complaint to, initiating communications with, or responding to any inquiry from, any government or regulatory agency or authority, including the U.S. Securities and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exchange Commission and the Ontario Securities Commission, regarding any good faith concerns about possible violations of law or regulation. Releasor does not need prior authorization from any Releasees to make any such reports or disclosures and Releasor is not required to notify any Releases that such reports or disclosures have been made. Despite the foregoing, Releasor is not permitted to reveal to any third party, including any government or regulatory agency or authority, information Releasor came to learn during Releasor&#8217;s service to the Employer that is protected from disclosure by any applicable privilege, including but not limited to the attorney-client privilege or attorney work product doctrine.  The Employer does not waive any applicable privileges or the right to continue to protect its privileged attorney-client information, attorney work product, and other privileged information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">ADDITIONAL REPRESENTATIONS AND WARRANTIES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor further represents and warrants that Releasor has not filed any civil action, suit, arbitration, administrative charge, or legal proceeding against any Releasees nor, has Releasor assigned, pledged, or hypothecated as of the Release Effective Date any Claim to any person and no other person has an interest in the Claims that he is releasing.  However, this representation does not apply to any charges, actions, or proceedings before, or engaging in communications with, the U.S. Securities and Exchange Commission or the Ontario Securities Commission about possible fraud or other securities law violations occurring prior to the date you execute this agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">ACKNOWLEDGMENT BY RELEASOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor acknowledges and agrees that Releasor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">has read this Release in its entirety and that this Release is a general release of all known and unknown Claims.  Releasor further acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:7.63pt">this Release does not release, waive or discharge any rights or Claims that may arise for actions or omissions after the Release Effective Date and Releasor acknowledges that he is not releasing, waiving or discharging any ADEA Claims that may arise after the Release Effective Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:4.58pt">Releasor is entering into this Release and releasing, waiving and discharging rights or Claims only in exchange for consideration which he is not already entitled to receive&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:1.53pt">Releasor has been advised, and is being advised by the Release, to consult with an attorney before executing this Release&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:2.13pt">Releasor has been advised, and is being advised by this Release, that he has been given at least twenty-one (21) days within which to consider the Release, but Releasor can execute this Release at any time prior to the expiration of such review period&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">Releasor is aware that this Release shall become null and void if he revokes his or her agreement to this Release within seven (7) days following the date of execution of this Release.  Releasor may revoke this Release at any time during such seven-day period by delivering (or causing to be delivered) to the Employer written notice of his or her revocation of this Release no later than 5&#58;00 p.m. Eastern time on the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) full day following the date of execution of this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Release (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Release Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Releasor agrees and acknowledges that a letter of revocation that is not received by such date and time shall be invalid and shall not revoke this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">COOPERATION WITH INVESTIGATIONS AND LITIGATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor agrees, upon the Employer&#8217;s reasonable request and consistent with Releasor&#8217;s reasonable business and personal obligations, to reasonably cooperate with the Employer in any investigation, litigation, arbitration or regulatory proceeding involving or relating to the Company or its affiliates, including making himself or herself reasonably available to consult with Employer&#8217;s counsel, to provide information and to give testimony.  Employer shall reimburse Releasor for reasonable out-of-pocket expenses Releasor incurs in extending such cooperation, so long as Releasor provides satisfactory documentation of the expenses.  Nothing in this Section is intended to, and shall not, restrict or limit Releasor from exercising his or her protected rights described in Sections 2, 4, 5 or 6 hereof or restrict or limit Releasor from providing truthful information in response to a subpoena, other legal process or valid governmental inquiry.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">RESTRICTIVE COVENANTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Releasor hereby affirms the restrictive covenants set forth in Article 7 of the Employment Agreement shall continue to apply following the Release Effective Date in accordance with their terms, subject to Releasor&#8217;s protected rights as set forth in Section 2(vi) of this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  To the extent not subject to federal law, this Release shall be governed by and construed in accordance with the law of the State of Delaware applicable to contracts made and to be performed entirely within that state.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">SEVERABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If any provision of this Release should be declared to be unenforceable by any administrative agency or court of law, then remainder of the Release shall remain in full force and effect.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">CAPTIONS&#59; SECTION HEADINGS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Captions and section headings used herein are for convenience only and are not a part of this Release and shall not be used in construing it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">COUNTERPARTS&#59; FACSIMILE SIGNATURES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Release may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original instrument without the production of any other counterpart.  Any signature on this Release, delivered by either party by photographic, facsimile or PDF shall be deemed to be an original signature thereto.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> I have hereunder set my hand this ____ day of April 2025.</font></div><div style="text-indent:72pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNED AND DELIVERED</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the presence of&#58;</font></div><div style="margin-top:36pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Witness Signature</font></div><div style="margin-top:36pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Print Name of Witness</font></div><div style="margin-top:36pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address of Witness</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:30pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:6.37pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JAMES HOLM</font></div></td></tr></table></div><div style="margin-bottom:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cron-20250319.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:478b2790-72bd-426c-9418-d37cb427892c,g:2f398438-9d39-48cc-adba-90bc3125063a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cron="http://thecronosgroup.com/20250319" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://thecronosgroup.com/20250319">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20250319_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20250319_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://thecronosgroup.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cron-20250319_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:478b2790-72bd-426c-9418-d37cb427892c,g:2f398438-9d39-48cc-adba-90bc3125063a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_095ad690-a172-463d-a75d-0e23dac9ed4b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2dbfc2fa-e9ed-484e-b0c1-2d8759e1d59a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_01eddc1a-0542-445f-82ab-ef295652a5e8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3b4f8848-4b04-4363-9cd4-cc0703237265_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_30144e9c-8d05-48a4-ba17-132e2890085b_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_c26d7552-f5d2-4aae-81b4-ab0a24d75f42_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c1d90f2f-7b3c-4893-bde8-bd698f5109c4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4dd7d28e-43ba-4c86-86d0-b7611bf37b3c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_7a5f11a2-5f98-4b6a-9715-a70c05001d52_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9640f9fb-a538-4270-97ae-05f309bcc0b2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_1b675ede-b0f3-4724-a245-194f640463df_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7770e25b-ed0d-4acf-9cc0-ee1be07114a5_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_763ed929-1591-4c74-9a14-969aa2e58793_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_be8b4530-2b49-4b94-bb12-d947b647da3e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d4136750-a935-4f76-b109-9e9ea9088726_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e5e8b641-d313-4ee8-bce1-ef17745a3b00_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_41a3236f-9f0c-4c93-a762-e2ed1ac4764e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6bf2ce01-de80-44b4-915b-65c990a19fa9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_f9556a2b-6ce7-49d2-8262-3bbcd391adf8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_fbd962a0-207c-4f99-a4f7-8c65ea814d0e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9aa91a5a-9960-49e6-b177-0791ffbd9419_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cron-20250319_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:478b2790-72bd-426c-9418-d37cb427892c,g:2f398438-9d39-48cc-adba-90bc3125063a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://thecronosgroup.com/role/CoverPage" xlink:type="simple" xlink:href="cron-20250319.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_00f17a99-051a-4b94-92e7-e759c850de3e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_DocumentType_00f17a99-051a-4b94-92e7-e759c850de3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f9a62590-e47b-4836-87c0-9eac0c2e1055" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_DocumentPeriodEndDate_f9a62590-e47b-4836-87c0-9eac0c2e1055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ca84fc09-156e-4fb9-a1fb-eff165740c22" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_EntityAddressStateOrProvince_ca84fc09-156e-4fb9-a1fb-eff165740c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9f37c8ed-443d-4fb8-a4ad-598fa5d975cf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9f37c8ed-443d-4fb8-a4ad-598fa5d975cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1bee3b87-8e0a-4a60-ab53-3f5619a089d8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_EntityFileNumber_1bee3b87-8e0a-4a60-ab53-3f5619a089d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_93d8c5c3-c8ce-4f5a-b4dd-b08c23f1cf44" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_EntityAddressAddressLine1_93d8c5c3-c8ce-4f5a-b4dd-b08c23f1cf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e33625db-d975-4ee8-ad1d-cffd7d5589f6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_EntityAddressCityOrTown_e33625db-d975-4ee8-ad1d-cffd7d5589f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_df6be5fd-eb5c-4afe-ad21-5aaeb534fdc6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_EntityAddressPostalZipCode_df6be5fd-eb5c-4afe-ad21-5aaeb534fdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_864308af-6fd7-4402-abb0-3d9f8029f0f4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_CityAreaCode_864308af-6fd7-4402-abb0-3d9f8029f0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8c7a5ad8-72cb-4c98-9b78-afddd7644c8d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_LocalPhoneNumber_8c7a5ad8-72cb-4c98-9b78-afddd7644c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_e12f1d29-0f27-4375-8d6d-fa3d21661bda" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_WrittenCommunications_e12f1d29-0f27-4375-8d6d-fa3d21661bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_8759d60c-a7bd-4296-97fa-59ff49cffc1d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_SolicitingMaterial_8759d60c-a7bd-4296-97fa-59ff49cffc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_32afecb6-3931-497a-ad57-a909c313a4e5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_PreCommencementTenderOffer_32afecb6-3931-497a-ad57-a909c313a4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_ec3a0eaf-33f5-4cbe-9c14-dd98cc29d823" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_ec3a0eaf-33f5-4cbe-9c14-dd98cc29d823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d68999bd-7976-4e22-b984-e5ac1b3acfe1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_Security12bTitle_d68999bd-7976-4e22-b984-e5ac1b3acfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4be1b681-1e7c-40a5-82cb-f0d0e82fc149" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_TradingSymbol_4be1b681-1e7c-40a5-82cb-f0d0e82fc149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_31e3b08f-8899-484f-b29a-3f998a8ed60a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_SecurityExchangeName_31e3b08f-8899-484f-b29a-3f998a8ed60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d3e138cc-3a2d-40bf-add4-8566a5ae33bc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_EntityEmergingGrowthCompany_d3e138cc-3a2d-40bf-add4-8566a5ae33bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7d1cc5bd-01eb-4ec6-b9c7-6d29f8fc8de2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_AmendmentFlag_7d1cc5bd-01eb-4ec6-b9c7-6d29f8fc8de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_54549012-66a6-4213-b328-64f02529f607" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_EntityRegistrantName_54549012-66a6-4213-b328-64f02529f607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d967ca25-7211-4ef7-92b6-f6f5c7fa445d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7f05d47f-ad3e-4abe-bd5f-855c7b8434d8" xlink:to="loc_dei_EntityCentralIndexKey_d967ca25-7211-4ef7-92b6-f6f5c7fa445d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ffd9dc8e-db59-4b47-8b0b-cb2013e8d051" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5d12adcd-7cec-41d9-873b-6fbfed04b193" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Aug. 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 19,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4491 Concession Rd 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">L0M 1S0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">504-0004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRON<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CRONOS GROUP INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001656472<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( (,\<UI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( (,\<UI:?5]C[@   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%*Q# 0AE]%<F^G:;%@Z.:RXDE!<$'Q%I+9
MW6#3A&2DW;>WC;M=1!_ 8V;^?/,-3*>#T#[B<_0!(UE,-Y/KAR1TV+ C41
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
MT%116F]?(+3E'S/X%<M4C66C 1-702:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8
M('_.;Z?D3EJ(X53"Q,!J9S]6:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\
M]L3MGXS*VG0T;1K@X_%X.+;+THMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1
MIJJ-4T_3]WW?ZYMHG J-6T_3:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]
MKFNDZ19H0D;CZWH2%;7E0-,@ %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1
M_L;%!-9ITAF6-$9RG9 %#@ WQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'
M@B'%W*_]]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ
M^R-;88<G;CL3<CH<9T)\S_;VD:4E,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV
M6'WV3T=N(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;X
MM,:L$> 3?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<
MHY=8%0&7&-\TJC4LQ=9XE<#QK9P\'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^
MG-- \)0O)/I*D8]ILR.G=";-Z#,:P4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS
M1B&$:;OP'J\DCIJMPA$K0CYB&38:<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^
M8,CLS9%USM:1#A&27C="/F+.BY 1OQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^
MAM4S;"R.]T?4%TKD#R:G/^DR- >CFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX
M"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$
M^ZXQVM<T+BAC5W+-R,=4KY,IV#F?P.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$D
MN/R+RO JQ GH9%LE"<M4TV4WBA*>0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/
M^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KTL<QP3A[+##MG/)(=MG>@'37[]EUVY".E
M,%.70[@:0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OG
MP5&PH^\\EAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@
M9& MH >#KU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB
M4CG":9@39ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB
M\QE3ON<K2<15.+]%,[82EQB\X^;'<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)
M+%N(61+B35WMU>>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(
M3)QYQ1$!=$4"(Y4<!A87,N10[I*0!A,!S93)1/ "@F2F'("8^@N]\@RY*17.
MK3XY?T4L@X9.7M(E$A2*L P%(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS
M<D/85"7SKMHF"X7;XE3-NQJ^)F!+PWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;
M>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!
M()O\UMND]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8
M\PRA9CC?AT6:&C/5BZPYC0IO0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^
M[PVPPL2.X>V+OP%02P,$%     @ @SQS6L/<)1Z\ P  9 T  !@   !X;"]W
M;W)K<VAE971S+W-H965T,2YX;6R5EV]SHS80QK^*ALYTVIG$((+_I;9G'"=W
MS=PE=NU<;Z:=OI!!!LV!1"41Q]^^*VQC=TK6US>V!.S#3[O+@QAME?YF,LXM
M>2MR:<9>9FUYZ_LFSGC!3$>57,*9C=(%LS#5J6]*S5E2!Q6Y'P9!SR^8D-YD
M5!];Z,E(5387DB\T,551,+V[X[G:CCWJ'0\L19I9=\"?C$J6\A6W7\J%AIG?
MJ"2BX-(()8GFF[$WI;=W=.@"ZBM^%WQKSL;$+66MU#<W>4S&7N"(>,YCZR08
M_+WR&<]SIP0<?Q]$O>:>+O!\?%3_4"\>%K-FAL]4_E4D-AM[ X\D?,.JW"[5
M]E=^6%#7Z<4J-_4OV>ZOO>E[)*Z,5<4A& @*(??_[.V0B+. </!.0'@("&ON
M_8UJRGMFV62DU99H=S6HN4&]U#H:X(1T55E9#6<%Q-G)3+UR3190@)%O0<\=
M]>-#[-T^-GPG=EJE'1(,KD@8A-&_PWW :%C"AB6L]6Y0EC^G:V,U5.NO-J*]
M0M2NX%KXUI0LYF,/>M1P_<J]R8\_T%[P"\)WT_#=8.J3>Q57T)"6O.S*UG3A
MX8/K3PA$U$!$WP>QX%JHA#S(A$#E6WEPI2>F.X0.KXBK7Q=!ZS9H753P05IA
M=V2:))![<W4<D,]P'9G+5D1<,8J&E,R4C$'&/</+A- 0(>TUI+W_1;I0QK*<
M_"%*N%O2"HH+?@Z>"%T%"%J_0>NC2K,:# SV71(\/J(]A&+04 SP]:@8\K'(
M%%3NN2K67+>1X!K=(+H.@@!SAF&#,T2EOFIA+9>0DJ*HI(B9<W33AH3K;%AN
M.,)#@Y-M!JC22N4B%E;(E#S!TZ<%RUL-%%>YR'-FXQ156FA^'4-V.#PK>X_B
M,@$WG6\V[;6[H'>1[&3J%/7D_Y(]&E,!V45 7/8BX,G5*>[++\+FG*@-6,M/
MZY_)BL<5M-NNE0E7<NT)+K7*&-C*%9&*E$R35Y97*.G)^BGNV"^:):[C5KMB
MK=K[#1>8+>?/&,G)Z2ENS,<DD8>W.&,R!9=@1?L6 A=ZGJ[NI[]A3"=/I]]E
MZ@\%UZG+TD=0L)GSC)+)]G+B@A=;[.3I%#?E*31^4C?_AYREK2BXP$64D[%3
MW)4/65KR5+AM%B"]6SE<R/72?$4^+N=?%N3Q>=;!\$Y&3W&'/N#-(%<:WD"/
MX!%OY!-O+Q\N!>\>VNOVHG[KCL$_VS.[[P_8#4'7&)+S#:@%G3[TK=YOZ?<3
MJ\IZ&[U6%C;E]3"#SR"NW05P?J.4/4[<SKSYL)K\ U!+ P04    " "#/'-:
MGZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKB
MD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;
M=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>
MW&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4
MD*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90S
MP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF
M8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,)
M;2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:
M\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9
ML^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ
M%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E
M\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%
M$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-
MLPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O
M-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=
M##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+
M P04    " "#/'-:EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P
M#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TX
MI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606
MIW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E
M_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU
M@LD/['X 4$L#!!0    ( (,\<UH9117U-P$  "<"   /    >&PO=V]R:V)O
M;VLN>&ULC5'1;L(P#/R5*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ
M&M)>]I3<V;K<7187XM.!Z)1\>1=B;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%A
ML&6L <2[=)IEL]1;#&:Y&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W
M!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6
MC>1FEJE@A1REW^CUK7H\@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<
M_U,C5146L*:B]1!DZ)'!=09#K+&))@G60VY6= 9.MO8(72A]95,. 46=W=3%
M<]0!;\K!XVBLA H#E&^J%977DHHM)]W1ZTSO'R:/6D;KW$JY]_!*MAQSCG^T
M_ %02P,$%     @ @SQS6B0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW
M+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB
M688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:
MY$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?
M#'!X=/X!4$L#!!0    ( (,\<UIED'F2&0$  ,\#   3    6T-O;G1E;G1?
M5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS
M3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV
M(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U
M2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z
M6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1
M.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_
M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ @SQS6D;'34B5
MS0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " "#/'-:6GU?8^X    K @  $0              @ '#    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " "#/'-:F5R<(Q &  "<)P  $P
M        @ '@ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( (,\
M<UK#W"4>O ,  &0-   8              " @2$(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " "#/'-:GZ ;\+$"  #B#   #0
M        @ $3#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( (,\<UJ7BKL<
MP    !,"   +              "  >\.  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( (,\<UH9117U-P$  "<"   /              "  =@/  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " "#/'-:)!Z;HJT   #X 0  &@
M    @ $\$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" "#/'-:99!YDAD!  #/ P  $P              @ $A$@  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  !K$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>17</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cron-20250319.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cron-20250319.htm">cron-20250319.htm</File>
    <File>cron-20250319.xsd</File>
    <File>cron-20250319_lab.xml</File>
    <File>cron-20250319_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="17">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cron-20250319.htm": {
   "nsprefix": "cron",
   "nsuri": "http://thecronosgroup.com/20250319",
   "dts": {
    "inline": {
     "local": [
      "cron-20250319.htm"
     ]
    },
    "schema": {
     "local": [
      "cron-20250319.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cron-20250319_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cron-20250319_pre.xml"
     ]
    }
   },
   "keyStandard": 17,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 22,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 17
   },
   "report": {
    "R1": {
     "role": "http://thecronosgroup.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cron-20250319.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cron-20250319.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001656472-25-000047-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001656472-25-000047-xbrl.zip
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MO.4V:HI!B^SQ?:!57^#*@90]>\<S^'MM%S8<:Z1+(A('6V4@S;1EDD+/]!$
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M%,P_^RRPTA71!/X9Z&%\_/]02P,$%     @ @SQS6NG+\ 9J @  # <  !$
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M    8W)O;BTR,#(U,#,Q.5]P<F4N>&ULU5K;;MM($GWW5VBUK]M67\EN(_;
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M_XB3ZR")__.'Y''T[-'C1\='ZO@H>OSLV702'1P>3)\_4=&C9Y/H\,G_'/X
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M^"R]P-FN),.U?_'HZ8,ZOT6=BX![FS?695+0KB4+2\2UK)2H^JZY&,(.,[L
M?]%CP^!/:"N@P,.V6[&-#*;WB3.?K16G[*X\LY^]AN=_GN/S[47A_IP9F&T>
MBR@ZT5/1QRR_274\0PMCKJJ6B+0%#4Z#)>C4"JU[0B* G/F:/ZE GV=YME?F
M:1(EE3L"\,,(MH"N$G.N7"<E_$N>BP=&L%1%Q8+8D%,%NP//(#Y<V!"J0$II
M2*F>P1T7N%DF"/O <R[!I#OL("O5=_'B?6R&,:9>T+$!,S6(UI!L\8&[1$W@
MY<$K_0R Q]K W.!W_O_."Q>_F^F]2:'5QSTUA6EXH=(;M2I_^$I8E.&A;MR
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ML$61M-5A1X+9DTWV%L\Z$?+J1J?7VO_:Q%+9D"&MS!;I,LFZBCTDQ!KJ1\$
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MWLQP@("E'\-@@JUBYPB#QCX.J5;PPVF:WV" DH*"(&2Y1;],^!RW7"D&1(,
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M]*G4^C2?[]Y])2VX/5&(XWL1A3@S/(?;$H6XR2D"43[$&WKC#4RU8^@16\*
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MCM#D*TZU @6JX1WR11)Q@V^XGX>-1SZ-JA4ATJTK8/4P]GF-+KKE:_#&)(N
MY:;4,Z^(^3RB)M!F'MO>%\4=_+&$GFOI%AM#4=$\@2-.NB2;;J%A,,]ON&2<
M%'Z6&V_-7(J]F!">FOE>+7?\EC0!K.?>;0MJ<AD[MWLXNZV97#\>GA D THU
M!52(8'@J8EPE"WE"P_E-,B?KB $RK1F'0T%8MV-D14+0K2Q*.P)$P.-"+>?M
M5*$\F8!(#3_;6ZZLKZ3"B+(7^C:VA"K+>K&4T#@-!ZY-B3TWH>8XR349,Y7I
M$>^_B2>+]!+>5H=_SO(\QHU6$6Q+!7P1D?1B9^]9QLWBV2)B969 R%PLA/W
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MOA2(5T$  XEKR6M0R5I.EBYX.F64+W4;A>YA#^FD<U'KHEW( 6,@A&.K L+
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M2ZB)!/=OI+3<NBJX'Y^,F:4XDN89,[\-TF@&_XR+2?SJ_P%02P$"% ,4
M" "#/'-:BPW>E4,7  #LB@  $0              @ $     8W)O;BTR,#(U
M,#,Q.2YH=&U02P$"% ,4    " "#/'-:Z<OP!FH"   ,!P  $0
M    @ %R%P  8W)O;BTR,#(U,#,Q.2YX<V102P$"% ,4    " "#/'-:Q"&/
MV+ )  #&4   %0              @ $+&@  8W)O;BTR,#(U,#,Q.5]L86(N
M>&UL4$L! A0#%     @ @SQS6LI?APC$!@  :C   !4              ( !
M[B,  &-R;VXM,C R-3 S,3E?<')E+GAM;%!+ 0(4 Q0    ( (,\<UK265@J
MQ&8  *6O @ >              "  >4J  !E>&AI8FET,3 Q+7-H;&EM86ME
M>&5C=71I=BYH=&U02P$"% ,4    " "#/'-:XS3B_0TF   $_P  '@
M        @ 'ED0  97AH:6)I=#$P,BUH;VQM<V5P87)A=&EO;F$N:'1M4$L%
3!@     &  8 G $  "ZX      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>cron-20250319_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cron-20250319.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2024-08-08</startDate>
            <endDate>2024-08-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-16">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-17">0001656472</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-03-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">CRONOS GROUP INC.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-4">4491 Concession Rd 12</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-5">L0M 1S0</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-6">416</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-7">504-0004</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-8">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-9">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-10">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-11">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-12">Common Shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-13">CRON</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-14">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-15">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
